A hiatal hernia does not directly cause cancer, but it creates conditions in the esophagus that substantially raise the risk of esophageal adenocarcinoma over time. The connection runs through chronic acid reflux and a precancerous condition called Barrett’s esophagus, both of which are far more common in people with hiatal hernias. One large study found that people with a hiatal hernia but no reflux symptoms still faced a roughly sixfold increase in esophageal adenocarcinoma risk, and that risk climbed further when reflux was also present. The relationship is real, well studied, and worth understanding in practical terms.
How a Hiatal Hernia Promotes Chronic Reflux
A hiatal hernia occurs when the upper part of the stomach pushes up through the diaphragm into the chest cavity. The diaphragm normally squeezes around the lower esophageal sphincter, a ring of muscle that keeps stomach contents from washing back up. When part of the stomach herniates through that opening, it disrupts the sphincter in several ways: it reduces the pressure that keeps the valve closed, it increases how often the sphincter relaxes inappropriately, and it impairs the esophagus’s ability to clear acid once reflux occurs.1PubMed Central. A new mechanism of gastroesophageal reflux in hiatal hernia documented by high-resolution impedance manometry: a case report Studies using pressure measurements inside the esophagus have shown that the frequency of these inappropriate relaxations is directly proportional to how far the stomach has slid out of position.2PubMed. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia
The size of the hernia makes a meaningful difference. Patients with larger hernias have weaker sphincters, more acid exposure, and worse mucosal injury compared to those with small or no hernias. Endoscopy in these patients reveals more severe esophagitis, and the damage tends to scale with hernia size.3The American Journal of Surgery. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury This chronic, escalating acid exposure is the engine that drives the link between hiatal hernias and cancer risk. The hernia itself is not malignant, but the environment it creates can set off a cascade of tissue changes over years and decades.
Barrett’s Esophagus as the Critical Intermediate Step
The normal lining of the esophagus is built for passing food, not for withstanding stomach acid. When acid reflux is persistent, the esophageal lining can undergo a transformation: the cells change into a type that more closely resembles intestinal tissue. This condition, Barrett’s esophagus, is the single most important precursor to esophageal adenocarcinoma. Not everyone with Barrett’s develops cancer, but almost all esophageal adenocarcinomas arise from Barrett’s tissue.
Hiatal hernias dramatically increase the odds of developing Barrett’s esophagus. A 2024 meta-analysis pooling data from 47 studies found that people with a hiatal hernia had roughly four times the risk of Barrett’s esophagus compared to those without one. The association held even after accounting for reflux symptoms and body weight.4PubMed Central. Association between hiatal hernia and Barrett’s esophagus: an updated meta-analysis with trial sequential analysis An earlier analysis found a nearly identical magnitude, with an overall odds ratio close to four and a particularly strong link in cases where the Barrett’s segment was long, where the risk jumped to about thirteenfold.5PubMed. Hiatal hernia and the risk of Barrett’s esophagus Long-segment Barrett’s carries a higher chance of progressing to cancer than the short-segment form, which makes this specific association especially concerning.
That the risk persists after adjusting for reflux is an important detail. It suggests that hiatal hernias contribute to Barrett’s through more than just acid reflux alone. Bile reflux, mechanical disruption, and chronic low-level inflammation at the junction where the esophagus meets the stomach all play roles. Older age, male sex, tobacco use, central obesity, and a family history of reflux-related disease are also recognized risk factors for Barrett’s.6Shackelford’s Surgery of the Alimentary Tract. Epidemiology of Barrett Esophagus and Risk Factors for Progression
From Barrett’s to Cancer and Why Hernia Size Matters
Barrett’s esophagus does not always progress to cancer. Most people with Barrett’s never develop malignancy. The progression runs through a stage called dysplasia, where the cells start showing abnormal features under a microscope but have not yet invaded deeper tissue. Dysplasia is graded as low or high, and high-grade dysplasia is essentially the last stop before cancer.
Hernia size appears to influence how likely someone with Barrett’s is to progress through those stages. A study tracking Barrett’s patients over time found that those with a hernia of 3 centimeters or larger were far more likely to develop worsening dysplasia than those with smaller hernias. Roughly 14% of the large-hernia group progressed, compared to about 4% with smaller hernias.7PubMed Central. The Impact of Hiatus Hernia Size on Dysplasia Progression in Patients With Barrett’s Esophagus Another analysis found that people with a hiatal hernia and Barrett’s had dramatically higher odds of both low-grade and high-grade dysplasia compared to Barrett’s patients without a hernia.8PubMed. Hiatal Hernia Associated with Higher Odds of Dysplasia in Patients with Barrett’s Esophagus
These findings have practical implications. If you’ve been diagnosed with Barrett’s esophagus, the size of an accompanying hiatal hernia gives your doctor additional information about your risk profile. A small hernia with short-segment Barrett’s is a different story than a large hernia with long-segment Barrett’s, and surveillance schedules can reflect that difference.
Direct Evidence Linking Hiatal Hernia to Esophageal Adenocarcinoma
Beyond the Barrett’s pathway, at least one major case-control study has looked at hiatal hernia as a standalone risk factor for esophageal adenocarcinoma. After adjusting for smoking, body size, and demographic factors, hiatal hernia and reflux symptoms each emerged as independent risk factors. Among people who had reflux symptoms alone, the odds of esophageal adenocarcinoma were about three and a half times higher than in people with neither condition. Among those with a hiatal hernia but no reflux symptoms, the risk was roughly sixfold. For people who had both a hernia and reflux symptoms, the odds climbed to about eightfold.9PubMed. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma
The finding that hiatal hernia carries elevated risk even without reflux symptoms is striking. It suggests that the anatomical displacement itself creates harmful conditions, possibly through bile reflux or mechanical irritation, that the patient may not feel as classic heartburn. In other words, the absence of symptoms doesn’t mean the absence of damage.
A family history of hiatal hernia may also be relevant. One case-control study found that having a first-degree relative with a hiatal hernia was associated with roughly double the odds of esophageal adenocarcinoma.10PubMed Central. Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case-control study This raises the question of whether genetic factors predispose some families to both hernias and esophageal cancer. There is some early evidence that a gene involved in connective tissue structure (on chromosome 2, related to collagen) is linked to both GERD susceptibility and hiatal hernia, particularly in men.11PubMed. Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia This is still early-stage research, but it hints at a shared biological vulnerability rather than pure coincidence.
What Happens at the Cellular Level
When the esophageal lining is repeatedly bathed in stomach acid mixed with bile, the damage goes deeper than surface irritation. Laboratory studies on Barrett’s cells have shown that bile acids, particularly deoxycholic acid, trigger the production of reactive oxygen species, which are highly aggressive molecules that damage DNA. At the same time, bile acid exposure activates a cellular pathway that helps damaged cells resist the normal self-destruct mechanism cells use when their DNA is too compromised to repair.12PubMed Central. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett’s epithelial cells The result is a dangerous combination: DNA is being damaged, and the damaged cells are surviving instead of dying off.
When bile salts are combined with an acidic environment, the DNA damage is even worse, because acid amplifies the production of those destructive reactive molecules.13Carcinogenesis. Prevention of DNA damage in Barrett’s esophageal cells exposed to acidic bile salts This is why chronic mixed reflux, acid plus bile, is especially hazardous and why hiatal hernias, which promote both types of reflux, create a particularly hostile environment for the esophageal lining.
The Role of Obesity and Shared Risk Factors
Hiatal hernia and esophageal adenocarcinoma share several risk factors, which complicates efforts to tease apart how much of the cancer risk is caused by the hernia itself versus by other things that tend to travel alongside it. Obesity is the most important shared factor. Excess abdominal fat increases pressure on the stomach, which promotes both hernia formation and reflux. But the connection between obesity and esophageal adenocarcinoma appears to go beyond just reflux. Research suggests that visceral fat tissue produces inflammatory signals, hormones, and growth factors that can fuel cancer development on their own.14PubMed. Obesity and increased risk of esophageal adenocarcinoma
This means weight management may offer dual benefits for people with hiatal hernias: it can reduce reflux severity and independently lower cancer risk through reduced inflammation. Smoking and male sex are other shared risk factors. The practical takeaway is that a hiatal hernia exists in a web of interconnected risks, and addressing the modifiable ones (weight and smoking, primarily) can shift your overall risk profile more than any single intervention targeting the hernia alone.
Can Acid-Suppressing Medications Help?
Proton pump inhibitors are the standard treatment for reflux, and there’s reasonable evidence that they reduce cancer risk in people with Barrett’s esophagus. One study of Barrett’s patients found that those using PPIs had a roughly 60% lower risk of progressing to more advanced disease, and prolonged use with good adherence provided additional protection.15Clinical Gastroenterology and Hepatology. Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett’s Esophagus A separate large Korean cohort study found that PPI use was associated with lower odds of death among people who had been diagnosed with esophageal cancer.16PubMed Central. Possible Association between the Use of Proton Pump Inhibitors and H2 Receptor Antagonists, and Esophageal Cancer: A Nested Case–Control Study Using a Korean National Health Screening Cohort
The logic is straightforward: if acid reflux drives tissue changes that lead to cancer, suppressing the acid should slow or halt those changes. The evidence supports this, though PPIs are not a guarantee. They reduce acid but do not fully prevent bile reflux, and they do not reverse Barrett’s tissue that has already formed.
Does Anti-Reflux Surgery Prevent Cancer?
If medications reduce cancer risk by controlling acid, it seems intuitive that surgical repair of the hernia and reflux would do even more. The evidence here is surprisingly discouraging. A Veterans Affairs cohort study found no significant difference in esophageal cancer rates between patients who had anti-reflux surgery (fundoplication) and those managed without surgery.17PubMed. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study A population-level study went further, finding that the rate of esophageal adenocarcinoma after anti-reflux surgery remained elevated. Cancers often developed more than five years after the procedure, even in patients whose surgery had successfully eliminated reflux symptoms.18European Journal of Cardio-Thoracic Surgery. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis
This doesn’t mean hernia repair is pointless. Surgery effectively treats reflux symptoms and can prevent complications like strictures. But if cancer prevention is the goal, surgery alone does not appear to be sufficient. People who have had anti-reflux surgery and who also have Barrett’s esophagus still need ongoing surveillance.
Surveillance in Barrett’s Esophagus
Because Barrett’s esophagus is the key precancerous stage, regular endoscopic surveillance is recommended for people with the diagnosis. The American Gastroenterological Association’s guidelines support scheduled surveillance, based in part on evidence that it catches early-stage cancers and high-grade dysplasia more reliably than a wait-and-see approach. In the BOSS trial, scheduled surveillance detected early-stage cancer or high-grade dysplasia in about 3.3% of patients compared to 1.2% in those who only got endoscopy when symptoms prompted it. Cancer-specific mortality was also meaningfully lower in surveilled patients.19Gastroenterology. American Gastroenterological Association Clinical Practice Guideline on Endoscopic Surveillance in Barrett’s Esophagus
How often you need surveillance depends on the length of your Barrett’s segment, whether dysplasia has been detected, and other risk factors. Given the evidence that hiatal hernia size accelerates dysplasia progression, some gastroenterologists weigh hernia size when deciding how aggressive to be with follow-up.
Beyond the Esophagus
Most of the cancer discussion around hiatal hernias centers on esophageal adenocarcinoma, but reflux can affect tissue beyond the esophagus. Laryngopharyngeal reflux, where stomach contents reach the throat and voice box, has been linked to mucosal damage in the larynx. A case report documented a patient with squamous cell cancer of the larynx who was subsequently found to have GERD driven by a hiatal hernia. The authors highlighted the possibility that chronic reflux reaching the larynx contributed to the cancer, and that treating the hernia and reflux could help prevent recurrence.20PubMed Central. Hiatal hernia repair and magnetic sphincter augmentation to treat laryngopharyngeal reflux aiding the prevention of recurrent laryngeal cancer This is far less studied than the esophageal connection and rests more on case-level evidence than on large epidemiological studies. But it underscores the principle that unchecked reflux can damage any tissue it reaches.
There is also growing interest in the role of the esophageal microbiome. In a healthy esophagus, the bacterial community is dominated by certain types of bacteria. In people with reflux esophagitis and Barrett’s esophagus, that community shifts toward a different microbial mix, and researchers are exploring whether this shift actively contributes to cancer development or is merely a marker of the inflamed environment.21PubMed Central. Microbiome in reflux disorders and esophageal adenocarcinoma The microbiome may interact with other risk factors like obesity, PPI use, and the absence of a bacterium called H. pylori, which has been declining in populations where esophageal adenocarcinoma has been rising.22PubMed Central. Alteration of the esophageal microbiota in Barrett’s esophagus and esophageal adenocarcinoma
When a Hiatal Hernia Mimics Cancer
An unusual but clinically important scenario involves hiatal hernias being mistaken for cancer during diagnostic workups. In one reported case, a large hiatal hernia compressed the distal esophagus enough to create varicose veins in the esophageal wall. On endoscopy, the lesion looked suspicious for malignancy, and a biopsy was taken. The biopsy triggered significant bleeding because the structure was vascular, not cancerous.23PubMed Central. Hiatal Hernia-Related Esophageal Varices Misdiagnosed as Cancer: Salvaged With Clipping This is rare, but it illustrates that large hernias can distort anatomy enough to create diagnostic confusion. Imaging before biopsy can help avoid these situations.
Hiatal Hernia After Esophageal Cancer Surgery
The relationship between hiatal hernias and esophageal cancer runs in both directions. When someone has surgery to remove esophageal cancer (esophagectomy), a hiatal hernia can develop as a complication afterward, because the operation alters the anatomy of the diaphragm and creates space for abdominal organs to herniate upward. In one series, hernia developed in about 6 to 8% of patients, appearing at a median of about 20 months after surgery.24The Annals of Thoracic Surgery. Hiatal Hernia After Esophagectomy for Cancer These post-surgical hernias range from incidental findings on follow-up imaging to surgical emergencies if the herniated tissue becomes trapped or loses its blood supply.25PubMed Central. Post-Esophagectomy Hiatal Hernia: A Case Series
For esophageal cancer patients who already had a hiatal hernia before their diagnosis, one small study found that having the hernia did not appear to worsen survival or disease-free outcomes after treatment. Three-year overall survival was comparable regardless of whether the patient had a pre-existing hernia.26Elsevier. Preoperative hiatal hernia in esophageal adenocarcinoma; does it have an impact on patient outcomes? That is reassuring, though the study was small and further confirmation would be welcome. It suggests that while the hernia contributes to the conditions that lead to cancer, once cancer is present and treated, the hernia’s influence on outcomes fades.